| Literature DB >> 29697855 |
Kok-Ann Gwee1,2, Warren Wei-Rhen Lee3, Khoon Lin Ling4, Choon Jin Ooi4, Seng Hock Quak5,6, Yock Young Dan3,7, Kewin Tien-Ho Siah7, James Guoxian Huang8,6, Andrew Seng Boon Chua9, Ida Normiha Hilmi10, Raja Affendi Raja Ali11, Christina Ong12, Marcellus Simadibrata13, Murdani Abdullah13, Jose D Sollano14, Somchai Leelakusolvong15, Sutep Gonlachanvit16, Yeong Yeh Lee17, Jane D Ricaforte-Campos18, Yee Kian Yin19, Kuck-Meng Chong20, Chong Yuen Wong21.
Abstract
The concept of consuming microorganisms in the treatment of a medical condition and in health maintenance has gained much attraction, giving rise to an abundance of medical claims and of health supplements. This study identified relevant clinical questions on the therapeutic use of probiotics and reviewed the literature in irritable bowel syndrome, inflammatory bowel disease, impaired intestinal immunity, liver disease, intestinal infections, and common childhood digestive disorders. Statements were developed to address these clinical questions. A panel of experienced clinicians was tasked to critically evaluate and debate the available data. Both consensus and contentious statements are presented to provide to clinicians a perspective on the potential of probiotics and importantly their limitations.Entities:
Keywords: Asia; childhood; gastrointestinal; liver; obesity; probiotics
Mesh:
Year: 2018 PMID: 29697855 DOI: 10.1111/jgh.14268
Source DB: PubMed Journal: J Gastroenterol Hepatol ISSN: 0815-9319 Impact factor: 4.029